OrganOx, a British developer of technologies to maintain organs for transplant, raised $142m in primary and secondary funding ...

OrganOx 's metra normothermic machine perfusion platform gained approval in Australia, Europe, Canada, and the US.

OrganOx announced today that it completed a $142 million primary and secondary equity financing to accelerate growth opportunities.

Financing strengthens OrganOx to expand its leadership position in organ technologyOXFORD, United Kingdom and MADISON, N.J., Feb. 24, 2025., a leading organ medical technology company, successfully co ...

OrganOx, with its system for actively preserving viable donor tissue ahead of a transplant procedure, has raised $142 million ...

Proper management of working capital is essential to a company’s fundamental financial health and operational success as a business. A hallmark of good business management is the ability to ...

Alphabet has gained about 9% so far this year. Wall Street had been expecting 2025 capital expenditures of about $58 billion, according to LSEG data. That would have marked a modest increase over ...

RICHMOND, Va. — The Capital Area Health Network has closed three of its medical centers in the Richmond area, citing unforeseen federal restrictions as the cause. The closures, which include the ...

Dick Kramlich, the venture capital pioneer who co-founded New Enterprise Associates almost 50 years ago and built it into a Silicon Valley powerhouse that regularly raised billion-dollar-plus ...

MIAMI, Feb. 3, 2025 /PRNewswire/ -- H.I.G. Capital ("H.I.G."), a leading global alternative investment firm with $67 billion of capital under management, is pleased to announce the sale of its ...